# Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More

> **NCT06293625** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 150 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Folfox
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT06293625
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-07
- **Primary completion:** 2032-06
- **Final completion:** 2032-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06293625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06293625, "Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT06293625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*